Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

XBiotech Inc. (XBIT)

21.16   0.97 (4.8%) 09-20 00:23
Open: 20.27 Pre. Close: 20.19
High: 21.19 Low: 19.895
Volume: 297,142 Market Cap: 613M
XBiotech, Inc. is a biopharmaceutical company. The company is headquartered in Austin, Texas and currently employs 58 full-time employees. The firm is engaged in discovering and developing True Human monoclonal antibodies for treating a range of different diseases. The company focuses on its lead product candidate, Xilonix (MABp1), which is derived from a natural human immune response. The firm has also developed a True Human monoclonal antibody discovery platform and manufacturing system. Xilonix is a therapeutic antibody, which specifically neutralizes interleukin-1 alpha (IL-1a). Its pipeline includes various human antibodies for treating diseases, such as cancer, vascular disease, inflammatory skin disease and diabetes. The firm has completed a Phase III study in Europe for the treatment of symptomatic colorectal cancer. The company also investigated its lead product candidate in clinical trials for other inflammatory conditions, including vascular disease, type II diabetes, acne, psoriasis, pyoderma gangrenosum (PG) and hidradenitis suppurativa (HS).

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 21.203 - 21.265 21.265 - 21.336
Low: 19.716 - 19.79 19.79 - 19.873
Close: 21.023 - 21.14 21.14 - 21.272

Technical analysis

as of: 2020-09-18 4:37:14 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 24.86     One year: 29.03
Support: Support1: 18.34    Support2: 16.52
Resistance: Resistance1: 21.28    Resistance2: 24.86
Pivot: 19.33
Moving Average: MA(5): 20.23     MA(20): 19.20
MA(100): 15.88     MA(250): 14.88
MACD: MACD(12,26): 0.89     Signal(9): 0.80
Stochastic oscillator: %K(14,3): 83.51     %D(3): 81.85
RSI: RSI(14): 67.88
52-week: High: 26.40  Low: 8.18  Change(%): 104.2
Average Vol(K): 3-Month: 20781  10-Days: 19827

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
XBIT has closed above the upper band by 5.9%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 21.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 18 Sep 2020
XBiotech Inc (NASDAQ:XBIT) Short Interest Update - MarketBeat

Tue, 01 Sep 2020
Stocks To Watch: XBiotech Inc. (XBIT) Is Creating Trading Opportunities - Invest Million

Fri, 28 Aug 2020
XBiotech Inc. (XBIT) Soars 3.07% on August 28 - Equities.com

Thu, 27 Aug 2020
Austin experts weigh in on convalescent plasma after FDA authorization - Austin Business Journal

Mon, 24 Aug 2020
XBiotech, AstraZeneca rise; Churchill Downs, Gilead fall | Business - Lincoln Journal Star

Mon, 24 Aug 2020
BUZZ-U.S. STOCKS ON THE MOVE-Apple Inc, Tesla Inc, XBiotech, Onconova Therapeutics - Nasdaq

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 29
Shares Float (M) 14
% Held by Insiders 67.34
% Held by Institutions 17.45
Shares Short (K) 2,040
Shares Short P. Month (K) 1,970

Stock Financials

EPS 15.240
EPS Est This Year -1.290
EPS Est Next Year -1.540
Book Value (p.s.) 11.890
Profit Margin 2390.03
Operating Margin -99.74
Return on Assets (ttm) -8.2
Return on Equity (ttm) 326.2
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share 0.972
EBITDA (p.s.) -0.891
Qtrly Earnings Growth
Operating Cash Flow (M) -81
Levered Free Cash Flow (M) -24

Stock Valuations

PE Ratio 1.39
PEG Ratio
Price to Book value 1.78
Price to Sales 21.77
Price to Cash Flow -7.58

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.